Since joining Risk Sciences International in 2019, Martin has served in Business Development, leading RSI’s business expansion efforts across Canadian and global markets. He is instrumental in identifying and qualifying opportunities, coordinating multidisciplinary proposal teams, developing project frameworks, and supporting contract negotiations. His expertise spans the entire procurement spectrum, including competitive tenders, standing offers, supply arrangements, and unsolicited proposals.

Dr. Emma Hartnett is Vice-President, Risk Modelling and Simulation at Risk Sciences International (RSI), where she has been a foundational member since its inception in 2006. A globally recognized authority in quantitative risk assessment (QRA), she specializes in developing risk models and decision support tools for complex public health and safety challenges across biological, chemical, and environmental domains.

Todd Ruthman serves as Vice‑President, Software and Modelling Solutions at Risk Sciences International (RSI) and has been with RSI since its founding in 2006. With a BASc in Systems Design Engineering from the University of Waterloo, Todd strives to understand the complex interactions in systems - a perspective that he channels into the design of data-driven, evidence-based decision-support applications for RSI’s clients. His team crafts custom IT solutions and leverages tools such as SQL Server, .NET,  Python, Excel, and R, to translate complex risk scenarios into interactive decision-support platforms.

Dr. Al-Zoughool has maintained a long-standing relationship with Risk Sciences International, both as a scientific collaborator and as a co-investigator on complex international projects. His work with RSI focuses on high-level public health risk modeling, mechanistic data analysis, and toxicological risk assessment of major environmental contaminants in air, soil, and water, including formaldehyde, lead, and 1,4-dioxane. His research also extends to methodological innovation and the development of evidence-based strategies for environmental and occupational health policy.

Dr. Paul Price is a Senior Analyst at Risk Sciences International (RSI), bringing over four decades of experience as a pioneer in exposure science and chemical risk assessment. Since joining RSI in 2019, Dr. Price has focused on advancing mixture risk assessment—an increasingly vital area as regulators shift from assessing single chemicals in isolation to understanding the cumulative effects of combined exposures. His current work includes the development of Mixture Adjustment Factors, participation in international regulatory committees, and authorship of scholarly publications aimed at refining the science-policy interface of chemical mixture risk.

Rosanna Wong is a Risk Analyst at Risk Sciences International (RSI), where she supports multidisciplinary projects at the intersection of climate resilience, food systems, and public safety. Since joining RSI in 2021, Rosanna has contributed to a broad range of research areas, including foodborne disease, intentional food adulteration, transportation and natural disaster risks, and climate change adaptation strategies.

Monique MacDonald is a seasoned Office Administrator with over thirty-five years of experience ensuring the smooth and efficient operation of office environments. She joined Risk Sciences International (RSI) in 2017, where she oversees the full range of internal operations and provides essential support across RSI’s scientific, operational, and client engagement activities. Her responsibilities include bookkeeping, financial support such as budgeting, invoicing, and expense tracking, as well as sales and marketing support. She also serves as operational and logistics coordinator for RSI’s convening events, including training sessions, workshops, and meetings.

Dr. Franco Momoli joined Risk Sciences International (RSI) in 2019 and currently serves as Vice-President, Chemical and Product Safety. In this role, he leads a multidisciplinary team of epidemiologists, risk assessors, toxicologists, and biostatisticians in conducting human health risk assessments related to environmental contaminants and consumer products. His practice group supports government agencies, regulatory bodies, and international partners in making science-informed decisions that safeguard public health.

Greg Paoli earned both his Bachelor's and Master's degrees from the University of Waterloo, specializing in engineering and systems design. His early career involved diverse research projects at the University of Waterloo's Institute for Risk Research. Greg later founded Decisionalysis Risk Consultants in 1997 and co-founded Risk Sciences International in 2006. He has served on multiple high-profile committees, including those under the U.S. National Academy of Sciences. As CEO of Risk Sciences International, Greg focuses on risk-based regulatory transformations and has developed enabling technologies like FDA-iRISK. His work spans various sectors, from food and chemical safety to public health, and he continues to contribute to the advancement of risk-based decision-making methodologies.

Dr. Natalia (Natasha) Shilnikova is a Senior Health Risk Analyst at Risk Sciences International (RSI), where she has contributed since 2011 to some of the organization’s most analytically demanding and policy-relevant projects. With a background in medicine and a PhD in medical sciences, Dr. Shilnikova specializes in the synthesis of epidemiological evidence, human health risk assessment, toxicology, and critical literature reviews—applying her expertise across a spectrum of regulatory and public health priorities.